Article
Researchers at the University of Montreal Health Center have created a prognostic tool that fills an important gap in forecasting early recurrence of disease following radical prostatectomy.
PSMA staging is linked with higher rates of ADT, ARPI utilization in prostate cancer
Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
RETAIN-2 interim data promising for dose-dense MVAC plus nivolumab in MIBC
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
Casdatifan is linked with promising safety, efficacy in clear cell RCC
Anktiva under review in UK for BCG-unresponsive NMIBC with CIS